Pharmacy Medical News about Plasmodium falciparum

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
Medicare Final Rule for 2010

Dorothy J. Schirf, MD

Technology Advances

Over-the-Counter Nanotech Test for Prostate Cancer Anticipated

Sara Hartley

Technology Advances

A New Strategy for Protecting Ovaries in Young Cancer Patients

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum
Trends in Parasitology, 11/03/09

Escalante AA et al. – The authors discuss current developments in population biology modeling and evolutionary genetics. Despite great advancements achieved in the past decade, understanding the complex dynamics of mutations conferring drug resistance in P. falciparum requires approaches that consider the parasite population structure among other demographic processes.

<< Previous
The brain angiotensin IV/AT4 receptor system as a new target for...

Next >>
Effect of glatiramer acetate on conversion to clinically definite...